Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial

To evaluate the non-inferiority of low dose efavirenz (400 mg) to standard dose efavirenz (600 mg), when taken in combination with tenofovir and lamivudine in Indian patients with HIV-1 infection. METHODS: An open-label, interventional phase IV study with blinded assessment was conducted across 17 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dravid, Ameet, Pilawan, Anant S., S., Anuradha, Morkar, Dnyanesh N., Ramapuram, John T, Madhukarrao, Kulkarni Milind, Naik, K. Sunil, Bhrusundi, Milind, K. R, Raveendra, Nageswaramma, Siddabathuni, Kulkarni, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726289/
https://www.ncbi.nlm.nih.gov/pubmed/36482530
http://dx.doi.org/10.1097/MD.0000000000031982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726289/
https://www.ncbi.nlm.nih.gov/pubmed/36482530
http://dx.doi.org/10.1097/MD.0000000000031982

Ejemplares similares